Laboratory Corp of America Holdings
Suletud
SektorTervishoid
255.92 -1.23
Ülevaade
Aktsiahinna muutus
24h
Min
254.31
Max
256.1
Sissetulek | 113M 278M |
|---|---|
Müük | 22M 3.5B |
P/E Sektori keskmine | 23.563 49.712 |
Aktsiakasum | 4.25 |
Dividenditootlus | 1.09 |
Kasumimarginaal | 7.858 |
Töötajad | 71,000 |
EBITDA | 130M 548M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +21.12% upside |
Dividenditootlus Sektori keskmine | 1.09% 2.36% |
|---|---|
Järgmine tulemuste avaldamine | 23. juuli 2026 |
Järgmine dividendimakse kuupäev | 10. sept 2026 |
Järgmine aktsia dividendi kuupäev (ex-date) | 27. aug 2026 |
Turukapital | 108M 22B |
|---|---|
Eelmine avamishind | 257.15 |
Eelmine sulgemishind | 255.92 |
Uudiste sentiment
By Acuity
50%
50%
118 / 342 Pingereas Healthcare
Laboratory Corp of America Holdings Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest Laboratory Corp of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.